| Literature DB >> 31041888 |
Hiroyuki Kanzaki1,2, Satoshi Wada3, Yuuki Yamaguchi3, Yuta Katsumata3, Kanako Itohiya3, Sari Fukaya3, Yutaka Miyamoto3, Tsuyoshi Narimiya3, Koji Noda3, Yoshiki Nakamura3.
Abstract
BACKGROUND: Osteoclasts play a critical role in bone resorption due to orthodontic tooth movement (OTM). In OTM, a force is exerted on the tooth, creating compression of the periodontal ligament (PDL) on one side of the tooth, and tension on the other side. In response to these mechanical stresses, the balance of receptor activator of nuclear-factor kappa-B ligand (RANKL) and osteoprotegerin (OPG) shifts to stimulate osteoclastogenesis. However, the mechanism of OPG expression in PDL cells under different mechanical stresses remains unclear. We hypothesized that compression and tension induce different microRNA (miRNA) expression profiles, which account for the difference in OPG expression in PDL cells. To study miRNA expression profiles resulting from OTM, compression force (2 g/cm2) or tension force (15% elongation) was applied to immortalized human PDL (HPL) cells for 24 h, and miRNA extracted. The miRNA expression in each sample was analyzed using a human miRNA microarray, and the changes of miRNA expression were confirmed by real-time RT-PCR. In addition, miR-3198 mimic and inhibitor were transfected into HPL cells, and OPG expression and production assessed.Entities:
Keywords: Mechanical stresses; MicroRNA; Orthodontic tooth movement; Osteoprotegerin; miR-3198
Year: 2019 PMID: 31041888 PMCID: PMC6449962 DOI: 10.1186/s12860-019-0187-2
Source DB: PubMed Journal: BMC Mol Cell Biol ISSN: 2661-8850
microarray analysis for miRNA expression
| control VS Compression | Log2 Ratio | control VS Tension | Log2 Ratio | Tension VS Compression | Log2 Ratio |
|---|---|---|---|---|---|
| hsa-miR-1268 | 9.94 | hsa-miR-3648 | 7.37 | hsa-miR-4299 | 11.10 |
| hsa-miR-572 | 7.73 | hsa-miR-1268 | 6.57 | hsa-miR-572 | 7.73 |
| hsa-miR-663 | 7.60 | hsa-miR-642b | 6.31 | hsa-miR-663 | 7.60 |
| hsa-miR-3648 | 7.21 | hsa-miR-135a | 5.35 | hsa-miR-575 | 6.87 |
| hsa-miR-575 | 6.87 | hsa-miR-376a | 5.21 | hsa-miR-3679-5p | 6.68 |
| hsa-miR-3679-5p | 6.68 | hsa-miR-4271 | 1.64 | hcmv-miR-UL70-3p | 6.57 |
| hsa-miR-642b | 6.64 | hsa-miR-136 | 1.47 | hsa-miR-3198 | 6.56 |
| hcmv-miR-UL70-3p | 6.57 | hsa-miR-29b | 1.36 | hsa-miR-1305 | 6.47 |
| hsa-miR-3198 | 6.56 | hsa-miR-3663-3p | 1.36 | hsa-miR-1225-3p | 6.31 |
| hsa-miR-1305 | 6.47 | hsv1-miR-H18 | 1.28 | hsa-miR-125a-3p | 6.16 |
| hsa-miR-1225-3p | 6.31 | hsa-miR-3656 | −1.04 | hsa-miR-1246 | 6.14 |
| hsa-miR-125a-3p | 6.16 | ebv-miR-BART13 | −1.16 | hsv1-miR-H17 | 5.88 |
| hsa-miR-1246 | 6.14 | hsa-miR-145 | −1.28 | hsa-miR-140-3p | 5.79 |
| hsv1-miR-H17 | 5.88 | hsa-miR-181b | −1.35 | hsa-miR-155 | 5.75 |
| hsa-miR-654-5p | 5.48 | hsa-miR-181a-2 | −1.42 | hsa-miR-654-5p | 5.48 |
| hsa-miR-135a | 5.43 | hsa-miR-503 | −4.99 | hsa-miR-129-3p | 5.37 |
| hsa-miR-129-3p | 5.37 | hsa-miR-425 | −5.43 | hsa-miR-874 | 5.36 |
| hsa-miR-874 | 5.36 | hsa-miR-425 | −5.61 | hsa-miR-425 | 5.26 |
| hsa-miR-4299 | 5.32 | hsa-miR-4299 | −5.78 | hsv1-miR-H7 | 5.26 |
| hsv1-miR-H7 | 5.26 | hsa-miR-155 | −5.87 | hsa-miR-485-3p | 5.26 |
microRNAs which target OPG (TNFRSF11b)
|
|
| ||||||
|---|---|---|---|---|---|---|---|
| RANK and miRNA | RANK and miRNA | ||||||
| 1 | hsa-miR-3163 | 26 | hsa-miR-135a | 1 | hsa-let-7f-2-3p | 26 | hsa-miR-6870-3p |
| 2 | hsa-miR-586 | 27 | hsa-miR-135b | 2 | hsa-miR-1185-1-3p | 27 | hsa-miR-936 |
| 3 | hsa-miR-633 | 28 | hsa-miR-200b | 3 | hsa-miR-1185-2-3p | 28 | hsa-miR-5692a |
| 4 | hsa-miR-656 | 29 | hsa-miR-590-5p | 4 | hsa-miR-4262 | 29 | hsa-miR-145-5p |
| 5 | hsa-miR-130b | 30 | hsa-miR-21 | 5 | hsa-miR-3163 | 30 | hsa-miR-5195-3p |
| 6 | hsa-miR-548c-3p | 31 | hsa-miR-4255 | 6 | hsa-miR-892c-5p | 31 | hsa-let-7c-3p |
| 7 | hsa-miR-590-3p | 32 | hsa-miR-4309 | 7 | hsa-miR-5584-5p | 32 | hsa-miR-216a-5p |
| 8 | hsa-miR-577 |
|
| 8 | hsa-miR-4729 | 33 | hsa-miR-4753-3p |
| 9 | hsa-miR-579 | 34 | hsa-miR-2054 | 9 | hsa-miR-181a-5p | 34 | hsa-miR-590-5p |
| 10 | hsa-miR-576-5p | 35 | hsa-miR-936 | 10 | hsa-miR-181c-5p | 35 | hsa-miR-3160-5p |
| 11 | hsa-miR-429 | 36 | hsa-miR-380 | 11 | hsa-miR-181d-5p | 36 | hsa-miR-429 |
| 12 | hsa-miR-488 | 37 | hsa-miR-3172 | 12 | hsa-miR-181b-5p | 37 | hsa-miR-200b-3p |
| 13 | hsa-miR-4262 | 38 | hsa-miR-376a | 13 | hsa-miR-3942-3p | 38 | hsa-miR-200c-3p |
| 14 | hsa-miR-181a | 39 | hsa-miR-376b | 14 | hsa-miR-4766-3p | 39 | hsa-miR-765 |
| 15 | hsa-miR-181b | 40 | hsa-miR-145 | 15 | hsa-miR-4668-5p | 40 | hsa-miR-5582-5p |
| 16 | hsa-miR-181c | 41 | hsa-miR-193b | 16 | hsa-miR-3942-5p | 41 | hsa-miR-629-5p |
| 17 | hsa-miR-181d | 42 | hsa-miR-4307 | 17 | hsa-miR-4294 | 42 | hsa-miR-6892-5p |
| 18 | hsa-miR-1283 | 43 | hsa-miR-765 | 18 | hsa-miR-4703-5p | 43 | hsa-miR-577 |
| 19 | hsa-let-7f-2 | 44 | hsa-miR-374a | 19 | hsa-miR-6501-3p | 44 | hsa-miR-579-3p |
| 20 | hsa-miR-889 | 45 | hsa-miR-29b-2 | 20 | hsa-miR-506-3p | 45 | hsa-miR-183-3p |
| 21 | hsa-miR-4294 | 46 | hsa-miR-570 | 21 | hsa-miR-124-3p | 46 | hsa-miR-6074 |
| 22 | hsa-miR-187 | 47 | hsa-miR-188-3p | 22 | hsa-miR-3662 | 47 |
|
| 23 | hsa-miR-200c | 48 | hsa-miR-222 | 23 | hsa-miR-130b-5p | 48 | hsa-miR-513b-3p |
| 24 | hsa-miR-506 | 49 | hsa-miR-3170 | 24 | hsa-miR-193b-5p | 49 | hsa-miR-7109-3p |
| 25 | hsa-miR-124 | 50 | hsa-miR-1323 | 25 | hsa-miR-5582-3p | 50 | hsa-miR-4309 |
miR-3198, which is found in the table 1, is indicated by boldface
Fig. 1miR-3198 and OPG were regulated differentially by compression and tension. The results of real-time RT-PCR analysis for miR-3198 (a), OPG (b), and RANKL (c) expression in HPL cells are shown. n = 3. Biological triplicated. Fold change from the control is displayed, with P < 0.05 versus control indicated by * and P < 0.05 between samples indicated by †. NS: not significant difference between the groups. Cont: control, press: compression, tens: tension. d Representative image of the western blotting (biological triplicate) for OPG is shown. e Relative band intensity of the western blotting for OPG. *: P < 0.05 versus control. †: P < 0.05 between the groups
Fig. 2miR-3198 gain-of-function and loss-of-function experiments. Results of real-time RT-PCR analysis for miR-3198 (a, b), OPG and RANKL (c, d) expression in HPL cells after transfection of miR-3198 inhibitor (a, c) and miR-3198 mimic (b, d). n = 3. Biological triplicated. Fold change from the control is shown. Open bar indicates the fold change of OPG expression, and close bar indicates that of RANKL expression (c, d). The concentrations of OPG as measured by ELISA after transfection of miR-3198 inhibitor (e) and miR-3198 mimic (f) are shown (n = 3). Results of real-time PCR analysis for miR-1207 (g, h), OPG and RANKL (i, j) expression in HPL cells under the transfection of miR-1207 inhibitor (g, i) and miR-1207 mimic (h, j). n = 3. Biological triplicated. Fold changes from the control are shown. * indicates P < 0.05 versus control, and NS indicating there was no significant difference between samples
Fig. 3miR-3198 regulates the mechanical stress-mediated change of OPG expression. Results of real-time RT-PCR analysis for OPG and RANKL expression in HPL cells in the compression (a) and tension (b) experiments. n = 3. Biological triplicated. Fold change from the control are shown. Cont, control; Inh, transfection of miR-3198 inhibitor; Mimic, transfection of miR-3198 mimic; press, compression; tens, tension; TF, transfection. Also shown are the OPG concentrations measured by ELISA in the compression (c) and tension (d) experiments (n = 3). * indicates P < 0.05 versus control. † indicates P < 0.05 between samples. NS indicates there was no significant difference between samples. e and f Representative image of the western blotting for OPG was shown. g and h Relative band intensity of the western blotting for OPG. *: P < 0.05 versus control. †: P < 0.05 between the groups. NS, no significant difference between the samples